Precision Wires India Receives In-Principal Approval for CCD Issue

Precision Wires India Ltd has secured in-principal approval for the issue of 3,750,000 Compulsorily Convertible Debentures (CCDs) at a face value of Rs 400 each.

Reader Takeaway: Regulatory approval clears the path for capital infusion, though compliance with SEBI allotment timelines remains mandatory.

What just happened

Precision Wires India Ltd obtained formal in-principal approval from both the BSE and the National Stock Exchange (NSE) on September 11, 2026. This allows the firm to move forward with its planned preferential issue of CCDs to non-promoter allottees. The total volume of the issuance stands at 3,750,000 instruments, each priced at a face value of Rs 400.

Why this matters

This approval represents a significant regulatory hurdle cleared in the company’s fundraising roadmap. For existing shareholders, it confirms that the process is moving ahead in alignment with SEBI regulations, ensuring that the company is on track to receive the planned capital infusion through these convertible instruments.

Regulatory Conditions and Compliance

The exchanges have mandated strict adherence to SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Precision Wires India is responsible for ensuring that allottees do not engage in intra-day trading or premature selling of the scrip before the final allotment is completed. The company must now finalize the allotment process within the prescribed statutory timeframes and subsequently file for the formal listing of these securities.

What to track next

Investors should monitor future exchange filings for confirmation of the successful allotment date and the eventual listing notice, which will mark the official entry of these new securities into the market ecosystem.